ID: ALA5181397

Max Phase: Preclinical

Molecular Formula: C12H16N4O3

Molecular Weight: 264.29

Representations

Canonical SMILES:  Nc1ncnn2c([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)ccc12

Standard InChI:  InChI=1S/C12H16N4O3/c13-12-9-2-1-8(16(9)15-5-14-12)7-3-6(4-17)10(18)11(7)19/h1-2,5-7,10-11,17-19H,3-4H2,(H2,13,14,15)/t6-,7+,10-,11+/m1/s1

Standard InChI Key:  MTASSMYEMRXLGU-KYAGDKKUSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 264.29

Molecular Weight (Monoisotopic): 264.1222

AlogP: -0.87

#Rotatable Bonds: 2

Polar Surface Area: 116.90

Molecular Species: NEUTRAL

HBA: 7

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.52

CX Basic pKa: 1.02

CX LogP: -1.37

CX LogD: -1.37

Aromatic Rings: 2

Heavy Atoms: 19

QED Weighted: 0.56

Np Likeness Score: 0.35

References

1. Khirsariya P, Pospíšil P, Maier L, Boudný M, Babáš M, Kroutil O, Mráz M, Vácha R, Paruch K..  (2022)  Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides.,  65  (7.0): [PMID:35302777] [10.1021/acs.jmedchem.1c02228]

Source

Source(1):

• Scientific Literature